BATS:WDNA

Wisdomtree Biorevolution Fund ETF News

etoro logo Buy WDNA
*Your capital is at risk
$19.04
+0.172 (+0.91%)
At Close: Jun 22, 2026
By Christopher Gannatti, CFA, Global Head of Research Key Takeaways In Q1 2025, the WisdomTree Efficient Gold Plus Gold Miners Strategy Fund (GDMN) led all performers, benefiting from a capital-effi
By Christopher Gannatti, CFA Key Takeaways Recent advancements in GLP-1 drugs, such as Ozempic and Wegovy, underscore their potential to transform health care by addressing obesity, cardiovascular dis

Why We Loved Bill Gates's Annual Letter

10:40am, Saturday, 06'th Jan 2024
By Christopher Gannatti, CFA, Global Head of Research We have been writing a lot about artificial intelligence (AI) and the ways in which we believe that topic will continue to evolve as the calenda

Wager on WDNA for Biotech Rebound

11:39am, Wednesday, 06'th Dec 2023
It's been a lengthy of stretch of subpar performance by biotech stocks and related exchange traded funds. That's a scenario that will repeat this year.

Multiple Reasons to Bet on Biotech ETF WDNA

01:26pm, Monday, 25'th Sep 2023
The healthcare sector is disappointing this year. And the ICE Biotechnology Index is even more of a dud on a year-to-date basis.

Can Health Care Stocks Outperform Again In 2023?

06:09pm, Wednesday, 11'th Jan 2023
How a recession could impact health care stocks in 2023. As Covid continues, what it could mean for the health care sector.
There are European politicians expressing support for the use of genetic modification techniques in agriculture. A certain bug-resistant strain of corn is the only genetically modified crop that has b
President Biden spoke at the Kennedy Presidential Library on the 60th anniversary of JFK's moonshot speech on Monday, September 12, outlining his plans for building out American research to end cancer
With an expanding global population and greater attention being paid to sustainability, novel approaches to agriculture may be at least as important in the long run. It's possible that precision breed
Equities are off to a dismal start to 2022, with high-growth and technology stocks, particularly shares of unprofitable companies, ranking among the worst offenders.
While WCLD's valuation premium has meaningfully contracted, its expected revenue growth over the benchmark Index has not.
Genomics represents one of the most disruptive, opportunity-rich investment frontiers, but stock picking in this space is tricky, to say the least. That underscores the utility of various genomics-ded
Investment strategies geared to the future evaluate complex dynamics that can evolve rapidly. As innovation's market share has grown, investment capacity - as measured by average days to trade - also

As New Healthcare Era Dawns, Consider WDNA

11:21am, Monday, 04'th Oct 2021
Investors looking for sector-level innovation beyond the technology realm don't need to stretch into unfamiliar territory — healthcare is prime territory for disruptive growth concepts. Several exch

Embrace WDNA as BioRevolution Gains Momentum

09:52am, Friday, 10'th Sep 2021
Investors looking for innovative companies and disruptive growth opportunities without excessive exposure to the technology sector would do well to check out healthcare. Arguably, healthcare is the mo
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE